BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 16327444)

  • 1. Association between ultrasound morphologic features and histopathological findings of lobular carcinoma.
    Malherbe K; Bresser P
    J Med Radiat Sci; 2019 Sep; 66(3):177-183. PubMed ID: 31472006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in atypical lobular hyperplasia: Striking a balance between active surveillance and minimally invasive interventions.
    Gao Y
    World J Surg; 2024 May; 48(5):1157-1158. PubMed ID: 38558225
    [No Abstract]   [Full Text] [Related]  

  • 3. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature.
    Elsheikh TM; Silverman JF
    Am J Surg Pathol; 2005 Apr; 29(4):534-43. PubMed ID: 15767810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive mammary carcinoma after immediate and short-term follow-up for lobular neoplasia on core biopsy.
    Crisi GM; Mandavilli S; Cronin E; Ricci A
    Am J Surg Pathol; 2003 Mar; 27(3):325-33. PubMed ID: 12604888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsy.
    Rendi MH; Dintzis SM; Lehman CD; Calhoun KE; Allison KH
    Ann Surg Oncol; 2012 Mar; 19(3):914-21. PubMed ID: 21861212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?
    Middleton LP; Grant S; Stephens T; Stelling CB; Sneige N; Sahin AA
    Mod Pathol; 2003 Feb; 16(2):120-9. PubMed ID: 12591964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lobular carcinoma in situ at percutaneous breast biopsy: surgical biopsy findings.
    Liberman L; Sama M; Susnik B; Rosen PP; LaTrenta LR; Morris EA; Abramson AF; Dershaw DD
    AJR Am J Roentgenol; 1999 Aug; 173(2):291-9. PubMed ID: 10430122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ.
    Crisi GM; Ricci A
    Am J Surg Pathol; 2005 Dec; 29(12):1684-5; author reply 1685-6. PubMed ID: 16327444
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancer upgrades at excisional biopsy after diagnosis of atypical lobular hyperplasia or lobular carcinoma in situ at core-needle biopsy: some reasons why.
    Cohen MA
    Radiology; 2004 Jun; 231(3):617-21. PubMed ID: 15163803
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of fine-needle aspiration cytology and core biopsy in the diagnosis of proliferative and atypical breast lesions.
    Maygarden SJ
    Anat Pathol; 1997; 2():165-96. PubMed ID: 9575375
    [No Abstract]   [Full Text] [Related]  

  • 11. The dilemma of lobular carcinoma in situ at percutaneous biopsy: to excise or to monitor.
    Gabriel H
    AJR Am J Roentgenol; 1999 Aug; 173(2):300-2. PubMed ID: 10430123
    [No Abstract]   [Full Text] [Related]  

  • 12. Recommendations for excision following core needle biopsy of the breast: a contemporary evaluation of the literature.
    Calhoun BC; Collins LC
    Histopathology; 2016 Jan; 68(1):138-51. PubMed ID: 26768035
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.